ArticleIEEE journal of translational engineering in health and medicine2025
Characterizing Navigational Changes in Preclinical Alzheimer's Disease: A Route Complexity Metric Derived From Naturalistic Driving Data.
Article in IEEE journal of translational engineering in health and medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
objectiveTo examine how early pathophysiological changes in Alzheimer's disease (AD) affect navigational decision-making by analyzing the complexity of driving routes in older adults with and without preclinical AD.
methodsWe developed a novel route complexity metric based on the number of left and right turns and the deviation from the most direct path, accounting for cognitive load during navigation. Naturalistic GPS driving data were collected for a year from 111 older adults aged 65-85, with preclinical AD status determined via cerebrospinal fluid amyloid biomarkers. A multiple linear regression model was used to assess the relationship between age, preclinical AD status, and route complexity.
resultsThe findings of this study indicate that preclinical AD may influence the navigational abilities of older adults. After controlling for age, participants with preclinical AD chose routes with higher baseline complexity than the control group. It further revealed that participants with preclinical AD selected routes with lower complexity as they aged-a trend not observed in healthy controls.
conclusionPreclinical AD is associated with changes in spatial decision-making that are observable in real-world driving behaviours. The age-related decline in route complexity among those with preclinical AD may reflect compensatory strategies or progressive cognitive changes. CLINICAL IMPACT: This study presents a non-invasive, behaviour-based metric that could support early detection of cognitive decline. It may also inform the design of personalized mobility interventions and dementia-friendly mobility systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.